• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
COVID-19 Management

Does Weight Loss Surgery for Obesity Reduce the Risk of Severe COVID-19?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Obesity is a risk factor for severe COVID-19 infection, but whether losing weight is associated with improved infection outcomes is unknown
  • Aminian et al. (JAMA Surg, 2021) investigated the association between a successful weight loss intervention following bariatric surgery and improved risk and severity of COVID-19 infection in patients with obesity

METHODS:

  • Retrospective, observational, matched-cohort study
    • Conducted at the Cleveland Clinic Health System
  • Population
    • Adult patients with a BMI ≥35 
    • Surgical group: Underwent weight loss surgery between January 2004 and December 2017
      • Roux-en-Y gastric bypass and sleeve gastrectomy
    • Control group: no surgical intervention for obesity
  • Exposures
    • SARS-CoV-2 infection
  • Study design
    • Outcomes were examined before and after COVID-19 outbreak on March 1, 2020
  • Primary outcomes
    • Positive SARS-CoV-2 test result
    • Hospitalization
    • Need for supplemental oxygen
    • Severe COVID-19 infection composite: ICU admission | Need for mechanical ventilation | Death

RESULTS:

  • 20,212 patients: 5053 underwent surgery | 15,159 control participants
    • Median (IQR) age: 46 (35 to 57) years
    • Median (IQR) BMI: 45 (41 to 51)
    • Median (IQR) follow-up duration: 6.1 (3.8 to 9.0) years
    • 77.6% female

Before the COVID-19 Outbreak

  • Patients in the surgical group
    • Lost more weight than the control group; P<0.001
      • Mean difference 10 years from baseline: 18.6 (95% CI, 18.4 to 18.7) percentage points
    • Had a 53% lower 10-year cumulative incidence of all-cause non–COVID-19 mortality; P<0.001
      • Surgical: 4.7% (95% CI, 3.7 to 5.7)
      • Control: 9.4% (95% CI, 8.7 to 10.1)

Following COVID-19 Outbreak

  • 11,809 patients had an assessment of COVID-19-related outcomes
  • Rates of positive SARS-CoV-2 test results were comparable in the surgical and control groups; P=0.71
    • Surgical: 9.1% (95% Ci, 7.9 to 10.3)
    • Control: 8.7% (95% CI, 8.0 to 9.3)
  • Undergoing weight loss surgery was associated with a lower risk of
    • Hospitalization
      • Adjusted hazard ratio (aHR) 0.51 (95% CI, 0.35 to 0.76); P<0.001
    • Need for supplemental oxygen
      • aHR 0.37 (95% CI, 0.23 to 0.61); P<0.001
    • Severe COVID-19 infection
      • aHR 0.40 (95% CI, 0.18 to 0.86); P=0.02

CONCLUSION:

  • For patients with obesity, weight loss through surgery was associated with better COVID-19 outcomes, compared to people with obesity who did not undergo surgical intervention
  • The authors state

Among patients with obesity, substantial weight loss achieved with surgery, compared with no surgery, was associated with a significantly lower risk of hospitalization, need for supplemental oxygen, and severe disease after contracting COVID-19 infection

The findings of this study suggest that obesity can be a modifiable risk factor for the severity of COVID-19 infection

Learn More – Primary Sources:

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection

Get Mobile-Friendly COVID-19 Research Summaries with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19 Management Posts
Next >

Related ObG Topics:

What are the Strongest Predictors of COVID-19 Hospitalization and Critical Illness?
Is Obesity an Independent Risk Factor for COVID-19 Related Mortality?
Pregnant Women with COVID-19 in France: Clinical Outcomes and Risk Factors for Severe Disease

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site